Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch Outcomes

被引:39
|
作者
Akiyama, Shintaro [1 ]
Ollech, Jacob E. [1 ]
Rai, Victoria [1 ]
Glick, Laura R. [1 ]
Yi, Yangtian [1 ]
Traboulsi, Cindy [1 ]
Runde, Joseph [2 ]
Cohen, Russell D. [1 ]
Skowron, Kinga B. [3 ]
Hurst, Roger D. [3 ]
Umanskiy, Konstantin [3 ]
Shogan, Benjamin D. [3 ]
Hyman, Neil H. [3 ]
Rubin, Michele A. [3 ]
Dalal, Sushila R. [1 ]
Sakuraba, Atsushi [1 ]
Pekow, Joel [1 ]
Chang, Eugene B. [1 ]
Rubin, David T. [1 ]
机构
[1] Univ Chicago, Med Inflammatory Bowel Dis Ctr, Dept Med, Chicago, IL 60637 USA
[2] Univ Chicago, Med Inflammatory Bowel Dis Ctr, Dept Pediat, Chicago, IL 60637 USA
[3] Univ Chicago, Med Inflammatory Bowel Dis Ctr, Dept Surg, Chicago, IL 60637 USA
关键词
Inflammatory Bowel Disease; Ileal Pouch-Anal Anastomosis; Pouchitis; Endoscopic Phenotype; Pouch Prognosis; CLOSTRIDIUM-DIFFICILE INFECTION; ILEAL POUCH; ANAL ANASTOMOSIS; RISK-FACTORS; ULCERATIVE-COLITIS; MICROBIOME; DIAGNOSIS;
D O I
10.1016/j.cgh.2021.02.010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Pouchitis is a common complication of ileal pouch-anal anastomosis (IPAA) in patients with ulcerative colitis who have undergone colectomy. Pouchitis has been considered a single entity despite a broad array of clinical and endoscopic patterns. We developed a novel classification system based on the pattern of inflammation observed in pouches and evaluated the contributing factors and prognosis of each phenotype. METHODS: We identified 426 patients (384 with ulcerative colitis) treated with proctocolectomy and IPAA who subsequently underwent pouchoscopies at the University of Chicago between June 1997 and December 2019. We retrospectively reviewed 1359 pouchoscopies and classified them into 7 main pouch phenotypes: (1) normal, (2) afferent limb involvement, (3) inlet involvement, (4) diffuse, (5) focal inflammation of the pouch body, (6) cuffitis, and (7) pouch with fistulas noted 6 months after ileostomy takedown. Logistic regression analysis was used to assess factors contributing to each phenotype. Pouch survival was estimated by the log-rank test and the Cox proportional hazards model. RESULTS: Significant contributing factors for afferent limb involvement were a body mass index of 25 or higher and hand-sewn anastomosis, for inlet involvement the significant contributing factor was male sex; for diffuse inflammation the significant contributing factors were extensive colitis and preoperative use of anti-tumor necrosis factor drugs, for cuffitis the significant contributing factors were stapled anastomosis and preoperative Clostridioides difficile infection. Inlet stenosis, diffuse inflammation, and cuffitis significantly increased the risk of pouch excision. Diffuse inflammation was associated independently with pouch excision (hazard ratio, 2.69; 95% CI, 1.34-5.41; P = .005). CONCLUSIONS: We describe 7 unique IPAA phenotypes with different contributing factors and outcomes, and propose a new classification system for pouch management and future interventional studies.
引用
收藏
页码:293 / +
页数:19
相关论文
共 50 条
  • [41] Expanding the horizons in interventional inflammatory bowel disease: endoscopic sinusotomy for the treatment of chronic pouch anastomotic sinus
    Navaneethan, Udayakumar
    Farraye, Francis A.
    GASTROINTESTINAL ENDOSCOPY, 2019, 89 (01) : 157 - 158
  • [42] Is ileoanal pouch excision a destination therapy for Inflammatory Bowel Disease? Data from a quaternary pouch referral center
    Choi, S.
    Lightner, A.
    Lipman, J.
    Hull, T.
    Steele, S.
    Holubar, S.
    Rieder, F.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S337 - S338
  • [43] IS ILEOANAL POUCH EXCISION A DESTINATION THERAPY FOR INFLAMMATORY BOWEL DISEASE? DATA FROM A QUATERNARY POUCH REFERRAL CENTER
    Choi, Sarah
    Lightner, Amy
    Lipman, Jeremy
    Hull, Tracy
    Steele, Scott
    Holubar, Stefan
    Rieder, Florian
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S15 - S16
  • [44] IS ILEOANAL POUCH EXCISION A DESTINATION THERAPY FOR INFLAMMATORY BOWEL DISEASE? DATA FROM A QUATERNARY POUCH REFERRAL CENTER
    Choi, Sarah
    Lightner, Amy L.
    Lipman, Jeremy M.
    Hull, Tracy L.
    Steele, Scott
    Holubar, Stefan D.
    GASTROENTEROLOGY, 2021, 160 (06) : S873 - S874
  • [45] IS ILEOANAL POUCH EXCISION A DESTINATION THERAPY FOR INFLAMMATORY BOWEL DISEASE? DATA FROM A QUATERNARY POUCH REFERRAL CENTER
    Choi, Sarah
    Lightner, Amy
    Lipman, Jeremy
    Hull, Tracy
    Steele, Scott
    Holubar, Stefan
    Rieder, Florian
    GASTROENTEROLOGY, 2021, 160 (03) : S20 - S21
  • [46] Classification and Management of Disorders of the J Pouch
    Santiago, Priscila
    Barnes, Edward L.
    Raffals, Laura E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (11): : 1931 - 1939
  • [47] POUCH ILEITIS - RECURRENCE OF THE INFLAMMATORY BOWEL-DISEASE IN THE ILEAL RESERVOIR
    KNOBLER, H
    LIGUMSKY, M
    OKON, E
    AYALON, A
    NESHER, R
    RACHMILEWITZ, D
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1986, 81 (03): : 199 - 201
  • [48] The inflammatory bowel disease disability index applied to ileal pouch anal anastomoses in New Zealand
    Lee, Y.
    McCombie, A.
    Gearry, R.
    Frizelle, F.
    Williman, J.
    Leong, R.
    Eglinton, T.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S321 - S322
  • [49] Clinical value of surveillance pouchoscopy in asymptomatic ileal pouch patients with underlying inflammatory bowel disease
    Hong Zhu
    Xian-rui Wu
    Elaine Queener
    Ravi P. Kiran
    Feza H. Remzi
    Bo Shen
    Surgical Endoscopy, 2013, 27 : 4325 - 4332
  • [50] Clinical value of surveillance pouchoscopy in asymptomatic ileal pouch patients with underlying inflammatory bowel disease
    Zhu, Hong
    Wu, Xian-rui
    Queener, Elaine
    Kiran, Ravi P.
    Remzi, Feza H.
    Shen, Bo
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2013, 27 (11): : 4325 - 4332